In very-high-risk patients with vascular disease, evolocumab slightly reduces nonfatal MI but not mortality (FOURIER)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "In Very-high-risk Patients With Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI but Not Mortality (FOURIER)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314306/all/In_very_high_risk_patients_with_vascular_disease__evolocumab_slightly_reduces_nonfatal_MI_but_not_mortality__FOURIER_.
In very-high-risk patients with vascular disease, evolocumab slightly reduces nonfatal MI but not mortality (FOURIER). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314306/all/In_very_high_risk_patients_with_vascular_disease__evolocumab_slightly_reduces_nonfatal_MI_but_not_mortality__FOURIER_. Accessed October 12, 2024.
In very-high-risk patients with vascular disease, evolocumab slightly reduces nonfatal MI but not mortality (FOURIER). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314306/all/In_very_high_risk_patients_with_vascular_disease__evolocumab_slightly_reduces_nonfatal_MI_but_not_mortality__FOURIER_
In Very-high-risk Patients With Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI but Not Mortality (FOURIER) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314306/all/In_very_high_risk_patients_with_vascular_disease__evolocumab_slightly_reduces_nonfatal_MI_but_not_mortality__FOURIER_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - In very-high-risk patients with vascular disease, evolocumab slightly reduces nonfatal MI but not mortality (FOURIER)
ID - 1314306
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314306/all/In_very_high_risk_patients_with_vascular_disease__evolocumab_slightly_reduces_nonfatal_MI_but_not_mortality__FOURIER_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -